Allelica, Inc. — Form D/A
Allelica, Inc. of ROME, L6, a company, filed a Form D amendment with the SEC on 2022-02-10. The offering totals $1.8M, of which $1.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-02-10
- Form: D/A
- Accession: 0001857831-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.8M
- Amount sold: $1.7M
- Remaining: $70K
- Investors: 8
- Date of first sale: 2021-03-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-396425
Issuer
- Name: Allelica, Inc.
- CIK: 0001857831
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: LARGO DELLA FONTANELLA DI BORGHESE 19, ROME, L6, 00186
- Phone: (470) 588-0420
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Giordano Botta | Director | Rome, L6 |
| Paolo Di Domenico | Director | Rome, L6 |
| Gary Peat | Director | Memphis, TN |
| Giordano Botta | Executive Officer | Rome, L6 |
Other filings by this issuer (1)
More